O Hospital Universitário Clementino Fraga Filho é o principal complexo médico-hospitalar da Universidade Federal do Rio de Janeiro, sendo considerado um dos mais importantes hospitais universitários do Brasil.

During the past decade, Hospital Universitario Clementino Fraga Filho conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 18 clinical trials were completed, i.e. on average, 81.8% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 9 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario Clementino Fraga Filho" #1 sponsor was "Universidade Federal do Rio de Janeiro" with 12 trials, followed by "Hoffmann-La Roche" with 6 trials sponsored, "Grupo de Estudos Multicentricos em Onco-Hematologia" with 4 trials sponsored, "Astellas Pharma Inc" with 3 trials sponsored and "Centers for Disease Control and Prevention" with 3 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Clementino Fraga Filho" #1 collaborator was "Conselho Nacional de Desenvolvimento Científico e Tecnológico" with 3 trials as a collaborator, "Financiadora de Estudos e Projetos" with 3 trials as a collaborator, "Rio de Janeiro State Research Supporting Foundation (FAPERJ)" with 3 trials as a collaborator, "Basilea Pharmaceutica International Ltd" with 2 trials as a collaborator and "OCT Clinical Trials" with 2 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario Clementino Fraga Filho" are "Crohn's Disease" (5 trials), "Crohn Disease" (4 trials), "Ulcerative Colitis" (4 trials), "Acromegaly" (3 trials) and "Colitis, Ulcerative" (3 trials). Many other conditions were trialed in "Hospital Universitario Clementino Fraga Filho" in a lesser frequency.

Most popular intervention types in "Hospital Universitario Clementino Fraga Filho" are "Drug" (42 trials), "Other" (9 trials), "Biological" (4 trials), "Behavioral" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (14 trials), "Dexamethasone" (3 trials), "Etrolizumab" (3 trials), "Guselkumab Dose 1" (2 trials) and "Guselkumab Dose 2" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario Clementino Fraga Filho" are 57 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Universitario Clementino Fraga Filho". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 39 completed trials in Hospital Universitario Clementino Fraga Filho, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario Clementino Fraga Filho, 3 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 11 trials that are defined as “Not Applicable".